Sanofi India posts 27% growth in operating profits in Q1 2025
Standalone profit from operations for the quarter were Rs. 162 crores
Standalone profit from operations for the quarter were Rs. 162 crores
For the full financial year FY25, revenue from operations grew 9 per cent to Rs. 11,537.8 crore, compared to Rs. 10,588 crore in FY24.
EBITDA before special items decreases to €4.08 billion (7.4%)
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
The CEP certification for Metformin Hydrochloride aligns with the company's strategy to penetrate stringently regulated markets
The Simplera Sync is a disposable, all-in-one sensor that requires no fingersticks with SmartGuard
Rising demands and advancements in eye care drive growth
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
Subscribe To Our Newsletter & Stay Updated